| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.45 | 0.002 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.74 | 0.004 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.35 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |